Literature DB >> 25211508

Pediatric brain tumor cell lines.

Jingying Xu1, Ashley Margol, Shahab Asgharzadeh, Anat Erdreich-Epstein.   

Abstract

Pediatric brain tumors as a group, including medulloblastomas, gliomas, and atypical teratoid rhabdoid tumors (ATRT) are the most common solid tumors in children and the leading cause of death from childhood cancer. Brain tumor-derived cell lines are critical for studying the biology of pediatric brain tumors and can be useful for initial screening of new therapies. Use of appropriate brain tumor cell lines for experiments is important, as results may differ depending on tumor properties, and can thus affect the conclusions and applicability of the model. Despite reports in the literature of over 60 pediatric brain tumor cell lines, the majority of published papers utilize only a small number of these cell lines. Here we list the approximately 60 currently-published pediatric brain tumor cell lines and summarize some of their central features as a resource for scientists seeking pediatric brain tumor cell lines for their research.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ATRT; EPENDYMOMA; GLIOMA; MEDULLOBLASTOMA; PEDIATRIC BRAIN TUMOR CELL LINES

Mesh:

Substances:

Year:  2015        PMID: 25211508     DOI: 10.1002/jcb.24976

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  27 in total

1.  Patient-derived cells modeling pediatric glioma.

Authors:  Anna Wenger; Susanna Larsson; Helena Carén
Journal:  Aging (Albany NY)       Date:  2017-05-08       Impact factor: 5.682

2.  Establishment of a novel human medulloblastoma cell line characterized by highly aggressive stem-like cells.

Authors:  Patrícia Benites Gonçalves da Silva; Carolina Oliveira Rodini; Carolini Kaid; Adriana Miti Nakahata; Márcia Cristina Leite Pereira; Hamilton Matushita; Silvia Souza da Costa; Oswaldo Keith Okamoto
Journal:  Cytotechnology       Date:  2015-09-10       Impact factor: 2.058

3.  BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells.

Authors:  Amanda Thomaz; Mariane Jaeger; Marienela Buendia; Victorio Bambini-Junior; Lauro José Gregianin; Algemir Lunardi Brunetto; André T Brunetto; Caroline Brunetto de Farias; Rafael Roesler
Journal:  J Mol Neurosci       Date:  2015-11-27       Impact factor: 3.444

4.  Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.

Authors:  Mariane Jaeger; Eduarda C Ghisleni; Lívia Fratini; Algemir L Brunetto; Lauro José Gregianin; André T Brunetto; Gilberto Schwartsmann; Caroline B de Farias; Rafael Roesler
Journal:  Childs Nerv Syst       Date:  2015-11-20       Impact factor: 1.475

5.  Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization.

Authors:  Shilpa Bhatia; Nimrah A Baig; Olga Timofeeva; Elena B Pasquale; Kellen Hirsch; Tobey J MacDonald; Anatoly Dritschilo; Yi Chien Lee; Mark Henkemeyer; Brian Rood; Mira Jung; Xiao-Jing Wang; Marcel Kool; Olga Rodriguez; Chris Albanese; Sana D Karam
Journal:  Oncotarget       Date:  2015-04-20

6.  A standardized and reproducible protocol for serum-free monolayer culturing of primary paediatric brain tumours to be utilized for therapeutic assays.

Authors:  Emma Sandén; Sofia Eberstål; Edward Visse; Peter Siesjö; Anna Darabi
Journal:  Sci Rep       Date:  2015-07-17       Impact factor: 4.379

7.  Feasibility and efficacy of an extended trial of home-based working memory training for pediatric brain tumor survivors: a pilot study.

Authors:  Bonnie Carlson-Green; Jennifer Puig; Anne Bendel
Journal:  Neurooncol Pract       Date:  2016-08-26

8.  Cytotoxic effects and tolerability of gemcitabine and axitinib in a xenograft model for c-myc amplified medulloblastoma.

Authors:  Andreas Beilhack; Matthias Wölfl; Stefanie Schwinn; Zeinab Mokhtari; Sina Thusek; Theresa Schneider; Anna-Leena Sirén; Nicola Tiemeyer; Ignazio Caruana; Evelina Miele; Paul G Schlegel
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

9.  SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression.

Authors:  Tara T Doucet-O'Hare; Brianna L DiSanza; Catherine DeMarino; Abigail L Atkinson; Jared S Rosenblum; Lisa J Henderson; Kory R Johnson; Jeffrey Kowalak; Marta Garcia-Montojo; Sariah J Allen; Brent A Orr; Mariarita Santi; Tongguang Wang; Saeed Fathi; Myoung Hwa Lee; Kevon Sampson; Wenxue Li; Zhengping Zhuang; Avindra Nath
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.996

10.  Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia.

Authors:  Jingying Xu; Ashley Sloane Margol; Anju Shukla; Xiuhai Ren; Jonathan L Finlay; Mark D Krieger; Floyd H Gilles; Fergus J Couch; Meraj Aziz; Eric T Fung; Shahab Asgharzadeh; Michael T Barrett; Anat Erdreich-Epstein
Journal:  Front Oncol       Date:  2015-08-27       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.